Print Page
4813
Stepping Down Asthma Medications: Benefits and Risks
Monday, March 3, 2014: 4:45 PM-6:00 PM
Convention Center, Mezzanine Level, Room 15AB
1.25 CME/ 1.50 CE
Moderator:
Chitra Dinakar , MD FAAAAI
Learning Objectives:
  1. Identify asthma patients who may be good candidates for stepping down their asthma medication
  2. Describe the risks associated with stepping down asthma medication with the best currently available evidence
  3. Compare and contrast different types of step down strategies
4:45 PM
Which Patients May Be Good Candidates for Stepping Down Asthma Medications?
Fernando D. Martinez, MD
5:00 PM
Understanding the Risks and Benefits of Stepping Down Asthma Medication
John B. Hagan, MD FAAAAI
Handouts
  • March 3 2014 4 45 pm For Syllabus Understanding the Risks and Benefits of Stepping Down Asthma Medication.pdf (643.5 kB)
    • 5:15 PM
    Comparing Asthma Step-Down Strategies: Is “Dynamic Dosing” Ready for Prime Time?
    Paul M. O'Byrne, MD FAAAAI
    5:30 PM
    Question & Answer
    See more of: Q & A Workshop
    << Previous Session | Next Session >>